Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

CCR Translations

  • CCR Translations
    The Challenge of Herbal Therapies for Prostate Cancer
    Rupal S. Bhatt and Glenn J. Bubley
    Clin Cancer Res December 1 2008 14 (23) 7581-7582; DOI:10.1158/1078-0432.CCR-08-2316

Molecular Pathways

  • Molecular Pathways
    Targeting the Kinesin Spindle Protein: Basic Principles and Clinical Implications
    Vasiliki Sarli and Athanassios Giannis
    Clin Cancer Res December 1 2008 14 (23) 7583-7587; DOI:10.1158/1078-0432.CCR-08-0120

  • Molecular Pathways
    Centromere-Associated Protein E: A Motor That Puts the Brakes on the Mitotic Checkpoint
    Kenneth W. Wood, Penelope Chua, David Sutton and Jeffrey R. Jackson
    Clin Cancer Res December 1 2008 14 (23) 7588-7592; DOI:10.1158/1078-0432.CCR-07-4443

Human Cancer Biology

  • Human Cancer Biology
    Cancer-Related Axonogenesis and Neurogenesis in Prostate Cancer
    Gustavo E. Ayala, Hong Dai, Michael Powell, Rile Li, Yi Ding, Thomas M. Wheeler, David Shine, Dov Kadmon, Timothy Thompson, Brian J. Miles, Michael M. Ittmann and David Rowley
    Clin Cancer Res December 1 2008 14 (23) 7593-7603; DOI:10.1158/1078-0432.CCR-08-1164

  • Human Cancer Biology
    Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer
    Kiyoshi Misawa, Yo Ueda, Takeharu Kanazawa, Yuki Misawa, Ilwhan Jang, John Chadwick Brenner, Tetsuya Ogawa, Satoru Takebayashi, Reidar A. Grenman, James G. Herman, Hiroyuki Mineta and Thomas E. Carey
    Clin Cancer Res December 1 2008 14 (23) 7604-7613; DOI:10.1158/1078-0432.CCR-07-4673

  • Human Cancer Biology
    14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness
    Divas Neupane and Murray Korc
    Clin Cancer Res December 1 2008 14 (23) 7614-7623; DOI:10.1158/1078-0432.CCR-08-1366

  • Human Cancer Biology
    Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
    Ugur Sahin, Michael Koslowski, Karl Dhaene, Dirk Usener, Gunda Brandenburg, Gerhard Seitz, Christoph Huber and Özlem Türeci
    Clin Cancer Res December 1 2008 14 (23) 7624-7634; DOI:10.1158/1078-0432.CCR-08-1547

  • Human Cancer Biology
    Perilobar Nephrogenic Rests Are Nonobligate Molecular Genetic Precursor Lesions of Insulin-Like Growth Factor-II-Associated Wilms Tumors
    Raisa Vuononvirta, Neil J. Sebire, Anthony R. Dallosso, Jorge S. Reis-Filho, Richard D. Williams, Alan Mackay, Kerry Fenwick, Anita Grigoriadis, Alan Ashworth, Kathy Pritchard-Jones, Keith W. Brown, Gordan M. Vujanic and Chris Jones
    Clin Cancer Res December 1 2008 14 (23) 7635-7644; DOI:10.1158/1078-0432.CCR-08-1620

  • Human Cancer Biology
    Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas
    Christine S. Walsh, Seishi Ogawa, Daniel R. Scoles, Carl W. Miller, Norihiko Kawamata, Steven A. Narod, H. Phillip Koeffler and Beth Y. Karlan
    Clin Cancer Res December 1 2008 14 (23) 7645-7651; DOI:10.1158/1078-0432.CCR-08-1291

  • Human Cancer Biology
    Ascites Specific Inhibition of CD1d-Mediated Activation of Natural Killer T Cells
    Tonya J. Webb, Robert L. Giuntoli II, Ophelia Rogers, Jonathan Schneck and Mathias Oelke
    Clin Cancer Res December 1 2008 14 (23) 7652-7658; DOI:10.1158/1078-0432.CCR-08-1468

  • Human Cancer Biology
    Role of Hedgehog Signaling in Ovarian Cancer
    Resham Bhattacharya, Junhye Kwon, Bushra Ali, Enfeng Wang, Sujata Patra, Viji Shridhar and Priyabrata Mukherjee
    Clin Cancer Res December 1 2008 14 (23) 7659-7666; DOI:10.1158/1078-0432.CCR-08-1414

  • Human Cancer Biology
    Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer
    Michael J. Callahan, Zoltan Nagymanyoki, Tomas Bonome, Michael E. Johnson, Babak Litkouhi, Elizabeth H. Sullivan, Michelle S. Hirsch, Ursula A. Matulonis, Joyce Liu, Michael J. Birrer, Ross S. Berkowitz and Samuel C. Mok
    Clin Cancer Res December 1 2008 14 (23) 7667-7673; DOI:10.1158/1078-0432.CCR-08-0479

  • Human Cancer Biology
    NGALR Is Overexpressed and Regulated by Hypomethylation in Esophageal Squamous Cell Carcinoma
    Lei Cui, Li-Yan Xu, Zhong-Ying Shen, Qian Tao, Shu-Ying Gao, Zhuo Lv, Ze-Peng Du, Wang-Kai Fang and En-Min Li
    Clin Cancer Res December 1 2008 14 (23) 7674-7681; DOI:10.1158/1078-0432.CCR-08-0420

  • Human Cancer Biology
    Constitutive Activation of Signal Transducer and Activator of Transcription 5 Contributes to Tumor Growth, Epithelial-Mesenchymal Transition, and Resistance to Epidermal Growth Factor Receptor Targeting
    Priya Koppikar, Vivian Wai Yan Lui, David Man, Sichuan Xi, Raymond Liu Chai, Elizabeth Nelson, Allison B.J. Tobey and Jennifer Rubin Grandis
    Clin Cancer Res December 1 2008 14 (23) 7682-7690; DOI:10.1158/1078-0432.CCR-08-1328

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α–Mediated Ceramide De novo Synthesis in Colon Cancer Cells
    Fabio Cianchi, Laura Papucci, Nicola Schiavone, Matteo Lulli, Lucia Magnelli, Maria Cristina Vinci, Luca Messerini, Clementina Manera, Elisa Ronconi, Paola Romagnani, Martino Donnini, Giuliano Perigli, Giacomo Trallori, Elisabetta Tanganelli, Sergio Capaccioli and Emanuela Masini
    Clin Cancer Res December 1 2008 14 (23) 7691-7700; DOI:10.1158/1078-0432.CCR-08-0799

  • Cancer Therapy: Preclinical
    Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis
    Yao Dai, Meilan Liu, Wenhua Tang, Jeffrey DeSano, Ezra Burstein, Mary Davis, Kenneth Pienta, Theodore Lawrence and Liang Xu
    Clin Cancer Res December 1 2008 14 (23) 7701-7710; DOI:10.1158/1078-0432.CCR-08-0188

  • Cancer Therapy: Preclinical
    Combination Immunotherapy for Tumors via Sequential Intratumoral Injections of Oncolytic Herpes Simplex Virus 1 and Immature Dendritic Cells
    Christopher J. Farrell, Cecile Zaupa, Zachary Barnard, Jason Maley, Robert L. Martuza, Samuel D. Rabkin and William T. Curry Jr.
    Clin Cancer Res December 1 2008 14 (23) 7711-7716; DOI:10.1158/1078-0432.CCR-08-1364

  • Cancer Therapy: Preclinical
    Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
    Patricia Goldhoff, Nicole M. Warrington, David D. Limbrick Jr., Andrew Hope, B. Mark Woerner, Erin Jackson, Arie Perry, David Piwnica-Worms and Joshua B. Rubin
    Clin Cancer Res December 1 2008 14 (23) 7717-7725; DOI:10.1158/1078-0432.CCR-08-0827

  • Cancer Therapy: Preclinical
    Imatinib Targeting of KIT-Mutant Oncoprotein in Melanoma
    Xiaofeng Jiang, Jun Zhou, Noah K. Yuen, Christopher L. Corless, Michael C. Heinrich, Jonathan A. Fletcher, George D. Demetri, Hans R. Widlund, David E. Fisher and F. Stephen Hodi
    Clin Cancer Res December 1 2008 14 (23) 7726-7732; DOI:10.1158/1078-0432.CCR-08-1144

  • Cancer Therapy: Preclinical
    Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival
    Hongkui Jin, Renhui Yang, Jed Ross, Sharon Fong, Richard Carano, Klara Totpal, David Lawrence, Zhong Zheng, Hartmut Koeppen, Howard Stern, Ralph Schwall and Avi Ashkenazi
    Clin Cancer Res December 1 2008 14 (23) 7733-7740; DOI:10.1158/1078-0432.CCR-08-0670

  • Cancer Therapy: Preclinical
    Cytokine Treatment Improves Parenchymal and Vascular Damage of Salivary Glands after Irradiation
    Isabelle M.A. Lombaert, Jeanette F. Brunsting, Pieter K. Wierenga, Harm H. Kampinga, Gerald de Haan and Robert P. Coppes
    Clin Cancer Res December 1 2008 14 (23) 7741-7750; DOI:10.1158/1078-0432.CCR-08-1449

  • Cancer Therapy: Preclinical
    Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2–Deficient Mouse Astrocytoma
    Jeremy Marsh, Purna Mukherjee and Thomas N. Seyfried
    Clin Cancer Res December 1 2008 14 (23) 7751-7762; DOI:10.1158/1078-0432.CCR-08-0213

  • Cancer Therapy: Preclinical
    Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70
    Julie A. McEarchern, Leia M. Smith, Charlotte F. McDonagh, Kerry Klussman, Kristine A. Gordon, Carol A. Morris-Tilden, Steven Duniho, Maureen Ryan, Tamar E. Boursalian, Paul J. Carter, Iqbal S. Grewal and Che-Leung Law
    Clin Cancer Res December 1 2008 14 (23) 7763-7772; DOI:10.1158/1078-0432.CCR-08-0493

  • Cancer Therapy: Preclinical
    Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice
    Rana P. Singh, Komal Raina, Girish Sharma and Rajesh Agarwal
    Clin Cancer Res December 1 2008 14 (23) 7773-7780; DOI:10.1158/1078-0432.CCR-08-1309

  • Cancer Therapy: Preclinical
    Maintenance Treatment with Bevacizumab Prolongs Survival in an In vivo Ovarian Cancer Model
    Seiji Mabuchi, Yoshito Terai, Kenichiro Morishige, Akiko Tanabe-Kimura, Hiroshi Sasaki, Masanori Kanemura, Satoshi Tsunetoh, Yoshimichi Tanaka, Masahiro Sakata, Robert A. Burger, Tadashi Kimura and Masahide Ohmichi
    Clin Cancer Res December 1 2008 14 (23) 7781-7789; DOI:10.1158/1078-0432.CCR-08-0243

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy
    David L. Blum, Tatsuki Koyama, Amosy E. M'Koma, Juan M. Iturregui, Magaly Martinez-Ferrer, Consolate Uwamariya, Joseph A. Smith Jr., Peter E. Clark and Neil A. Bhowmick
    Clin Cancer Res December 1 2008 14 (23) 7790-7797; DOI:10.1158/1078-0432.CCR-08-1716

  • Imaging, Diagnosis, Prognosis
    Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
    Sara Ekeblad, Britt Skogseid, Kristina Dunder, Kjell Öberg and Barbro Eriksson
    Clin Cancer Res December 1 2008 14 (23) 7798-7803; DOI:10.1158/1078-0432.CCR-08-0734

  • Imaging, Diagnosis, Prognosis
    Association between CCND1 G/A870 Polymorphism, Allele-Specific Amplification, Cyclin D1 Expression, and Survival in Esophageal and Lung Carcinoma
    Vanita K. Gupta, Andrew Feber, Liqiang Xi, Arjun Pennathur, Maoxin Wu, James D. Luketich and Tony E. Godfrey
    Clin Cancer Res December 1 2008 14 (23) 7804-7812; DOI:10.1158/1078-0432.CCR-08-0744

  • Imaging, Diagnosis, Prognosis
    Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
    Stefan Holdenrieder, Joachim von Pawel, Elke Dankelmann, Thomas Duell, Bernhard Faderl, Andreas Markus, Maria Siakavara, Horst Wagner, Knut Feldmann, Harald Hoffmann, Hannelore Raith, Dorothea Nagel and Petra Stieber
    Clin Cancer Res December 1 2008 14 (23) 7813-7821; DOI:10.1158/1078-0432.CCR-08-0678

  • Imaging, Diagnosis, Prognosis
    Heat Shock Protein 90 Overexpression Independently Predicts Inferior Disease-Free Survival with Differential Expression of the α and β Isoforms in Gastrointestinal Stromal Tumors
    Chien-Feng Li, Wen-Wei Huang, Jing-Mei Wu, Shih-Chen Yu, Tsung-Hui Hu, Yih-Huei Uen, Yu-Fang Tian, Ching-Nan Lin, David Lu, Fu-Min Fang and Hsuan-Ying Huang
    Clin Cancer Res December 1 2008 14 (23) 7822-7831; DOI:10.1158/1078-0432.CCR-08-1369

  • Imaging, Diagnosis, Prognosis
    Elevated Phospho-S6 Expression Is Associated with Metastasis in Adenocarcinoma of the Lung
    J. Matthew McDonald, Christopher E. Pelloski, Alicia Ledoux, Menghong Sun, Gabriela Raso, Ritsuko Komaki, Ignacio I. Wistuba, B. Nebiyou Bekele and Ken Aldape
    Clin Cancer Res December 1 2008 14 (23) 7832-7837; DOI:10.1158/1078-0432.CCR-08-0565

  • Imaging, Diagnosis, Prognosis
    Distinct Subcellular Expression Patterns of Neutral Endopeptidase (CD10) in Prostate Cancer Predict Diverging Clinical Courses in Surgically Treated Patients
    Achim Fleischmann, Thorsten Schlomm, Hartwig Huland, Jens Köllermann, Philipp Simon, Martina Mirlacher, Georg Salomon, Felix H.K. Chun, Thomas Steuber, Ronald Simon, Guido Sauter, Markus Graefen and Andreas Erbersdobler
    Clin Cancer Res December 1 2008 14 (23) 7838-7842; DOI:10.1158/1078-0432.CCR-08-1432

  • Imaging, Diagnosis, Prognosis
    High Expression of HER3 Is Associated with a Decreased Survival in Gastric Cancer
    Mikiko Hayashi, Mikito Inokuchi, Yoko Takagi, Hiroyuki Yamada, Kazuyuki Kojima, Jiro Kumagai, Tatsuyuki Kawano and Kenichi Sugihara
    Clin Cancer Res December 1 2008 14 (23) 7843-7849; DOI:10.1158/1078-0432.CCR-08-1064

  • Imaging, Diagnosis, Prognosis
    Analysis of Gene Expression in Early-Stage Ovarian Cancer
    Sergio Marchini, Pietro Mariani, Giovanna Chiorino, Eleonora Marrazzo, Riccardo Bonomi, Robert Fruscio, Luca Clivio, Annalisa Garbi, Valter Torri, Michela Cinquini, Tiziana Dell'Anna, Giovanni Apolone, Massimo Broggini and Maurizio D'Incalci
    Clin Cancer Res December 1 2008 14 (23) 7850-7860; DOI:10.1158/1078-0432.CCR-08-0523

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
    Michael F. Press, Richard S. Finn, David Cameron, Angelo Di Leo, Charles E. Geyer, Ivonne E. Villalobos, Angela Santiago, Roberta Guzman, Armen Gasparyan, Yanling Ma, Kathy Danenberg, Anne Marie Martin, Lisa Williams, Cristina Oliva, Steven Stein, Robert Gagnon, Michael Arbushites and Maria T. Koehler
    Clin Cancer Res December 1 2008 14 (23) 7861-7870; DOI:10.1158/1078-0432.CCR-08-1056

  • Cancer Therapy: Clinical
    VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy
    Harold J. Burstein, Yu-Hui Chen, Leroy M. Parker, Jennifer Savoie, Jerry Younger, Irene Kuter, Paula D. Ryan, Judy E. Garber, Helen Chen, Susana M. Campos, Lawrence N. Shulman, Lyndsay N. Harris, Rebecca Gelman and Eric P. Winer
    Clin Cancer Res December 1 2008 14 (23) 7871-7877; DOI:10.1158/1078-0432.CCR-08-0593

  • Cancer Therapy: Clinical
    A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer
    Maura N. Dickler, Hope S. Rugo, Carey A. Eberle, Edi Brogi, James F. Caravelli, Katherine S. Panageas, Jeff Boyd, Benjamin Yeh, Diana E. Lake, Chau T. Dang, Teresa A. Gilewski, Jacqueline F. Bromberg, Andrew D. Seidman, Gabriella M. D'Andrea, Mark M. Moasser, Michele Melisko, John W. Park, Janet Dancey, Larry Norton and Clifford A. Hudis
    Clin Cancer Res December 1 2008 14 (23) 7878-7883; DOI:10.1158/1078-0432.CCR-08-0141

  • Cancer Therapy: Clinical
    Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab
    Georg Lurje, Fumio Nagashima, Wu Zhang, Dongyun Yang, Heung M. Chang, Michael A. Gordon, Anthony El-Khoueiry, Hatim Husain, Peter M. Wilson, Robert D. Ladner, David J. Mauro, Christiane Langer, Eric K. Rowinsky and Heinz-Josef Lenz
    Clin Cancer Res December 1 2008 14 (23) 7884-7895; DOI:10.1158/1078-0432.CCR-07-5165

  • Cancer Therapy: Clinical
    FAS Promoter Polymorphism: Outcome of Childhood Acute Myeloid Leukemia. A Children's Oncology Group Report
    Parinda A. Mehta, Robert B. Gerbing, Todd A. Alonzo, James S. Elliott, Tiffany A. Zamzow, Michelle Combs, Emily Stover, Julie A. Ross, John P. Perentesis, Soheil Meschinchi, Beverly J. Lange and Stella M. Davies
    Clin Cancer Res December 1 2008 14 (23) 7896-7899; DOI:10.1158/1078-0432.CCR-08-0418

  • Cancer Therapy: Clinical
    Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data
    Julian R. Molina, Scott H. Kaufmann, Joel M. Reid, Stephen D. Rubin, Marina Gálvez-Peralta, Robert Friedman, Karen S. Flatten, Kevin M. Koch, Tona M. Gilmer, Robert J. Mullin, Roxanne C. Jewell, Sara J. Felten, Sumithra Mandrekar, Alex A. Adjei and Charles Erlichman
    Clin Cancer Res December 1 2008 14 (23) 7900-7908; DOI:10.1158/1078-0432.CCR-08-0415

  • Cancer Therapy: Clinical
    Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer
    Stacy L. Moulder, W. Fraser Symmans, Daniel J. Booser, Timothy L. Madden, Cindy Lipsanen, Linda Yuan, Abenaa M. Brewster, Massimo Cristofanilli, Kelly K. Hunt, Thomas A. Buchholz, James Zwiebel, Vicente Valero, Gabriel N. Hortobagyi and Francisco J. Esteva
    Clin Cancer Res December 1 2008 14 (23) 7909-7916; DOI:10.1158/1078-0432.CCR-08-1104

  • Cancer Therapy: Clinical
    Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
    Ruth Plummer, Christopher Jones, Mark Middleton, Richard Wilson, Jeffrey Evans, Anna Olsen, Nicola Curtin, Alan Boddy, Peter McHugh, David Newell, Adrian Harris, Patrick Johnson, Heidi Steinfeldt, Raz Dewji, Diane Wang, Lesley Robson and Hilary Calvert
    Clin Cancer Res December 1 2008 14 (23) 7917-7923; DOI:10.1158/1078-0432.CCR-08-1223

  • Cancer Therapy: Clinical
    Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
    Alejandro D. Ricart, Anthony W. Tolcher, Glenn Liu, Kyle Holen, Garry Schwartz, Mark Albertini, Geoffrey Weiss, Salim Yazji, Chee Ng and George Wilding
    Clin Cancer Res December 1 2008 14 (23) 7924-7929; DOI:10.1158/1078-0432.CCR-08-0378

  • Cancer Therapy: Clinical
    Tissue Levels of Reduced Folates in Patients with Colorectal Carcinoma After Infusion of Folinic Acid at Various Dose Levels
    Marcus Schlemmer, Michael Kuehl, Andreas Schalhorn, Josefine Rauch, Karl-W. Jauch and Marcus Hentrich
    Clin Cancer Res December 1 2008 14 (23) 7930-7934; DOI:10.1158/1078-0432.CCR-08-0258

  • Cancer Therapy: Clinical
    A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function
    Marco Siano, Erika Lerch, Laura Negretti, Emanuele Zucca, Delvys Rodriguez-Abreu, Michel Oberson, Leda Leoncini, Oreste Mora, Cristiana Sessa, Augusto Gallino and Michele Ghielmini
    Clin Cancer Res December 1 2008 14 (23) 7935-7939; DOI:10.1158/1078-0432.CCR-08-1124

  • Cancer Therapy: Clinical
    A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
    Elisabeth I. Heath, David W. Hillman, Ulka Vaishampayan, Shijie Sheng, Fazlul Sarkar, Felicity Harper, Melvin Gaskins, Henry C. Pitot, Winston Tan, S. Percy Ivy, Roberto Pili, Michael A. Carducci, Charles Erlichman and Glenn Liu
    Clin Cancer Res December 1 2008 14 (23) 7940-7946; DOI:10.1158/1078-0432.CCR-08-0221

  • Cancer Therapy: Clinical
    Phase I, Pharmacokinetic and Biological Correlative Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor, and Cisplatin in Patients with Solid Tumors
    Alejandro D. Ricart, Jordan D. Berlin, Kyriakos P. Papadopoulos, Samira Syed, Daniel W. Drolet, Charlotte Quaratino-Baker, Julie Horan, Jon Chick, Wendy Vermeulen, Anthony W. Tolcher, Eric K. Rowinsky and Mace L. Rothenberg
    Clin Cancer Res December 1 2008 14 (23) 7947-7955; DOI:10.1158/1078-0432.CCR-08-0864

Cancer Prevention and Susceptibility

  • Cancer Prevention and Susceptibility
    Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma
    Yohei Horikawa, Christopher G. Wood, Hushan Yang, Hua Zhao, Yuanqing Ye, Jian Gu, Jie Lin, Tomonori Habuchi and Xifeng Wu
    Clin Cancer Res December 1 2008 14 (23) 7956-7962; DOI:10.1158/1078-0432.CCR-08-1199

Corrections

  • Corrections
    Correction: Article on PI3K p85α Genetic Polymorphism and Colon Cancer Risk
    Clin Cancer Res December 1 2008 14 (23) 7963-7963; DOI:10.1158/1078-0432.CCR-14-23-COR1

  • Corrections
    Correction: Article on CD44 As a Marker of Colorectal Cancer Stem Cells
    Clin Cancer Res December 1 2008 14 (23) 7964-7967; DOI:10.1158/1078-0432.CCR-14-23-COR2

Back to top
PreviousNext
Clinical Cancer Research: 14 (23)
December 2008
Volume 14, Issue 23
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Targeting the Kinesin Spindle Protein: Basic Principles and Clinical Implications
  • 14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness
  • Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
  • Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival

Jump to

  • CCR Translations
  • Molecular Pathways
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Prevention and Susceptibility
  • Corrections
Advertisement
  • Most Cited
  • Most Read
Loading
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • FLASH-RT Spares Lung Progenitor Cells
  • AR Gene Rearrangements in Prostate Cancer
  • PDAC and GATA6 Expression
  • Guadecitabine and Carboplatin in Ovarian Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement